KRAS and pancreatic neoplasm: NCT01676259 is investigating siG12D-LODER, a novel biodegradable polymeric matrix containing an siRNA targeting mutated KRAS (KRAS G12X mutation) in advanced pancreatic cancer patients undergoing chemotherapy [151].